Hepatic Dysfunction with Systemic Antifungal Agents
DOI:
https://doi.org/10.5915/18-3_4-12803Keywords:
Ketoconazole, Fungal infection, Side effects, LiverAbstract
DOI: http://dx.doi.org/10.5915/18-3_4-12803
Successful therapy of many systemic fungal infections has been possible with the availability of several antifungal agents. However, most of these drugs may have potential hepatotoxic side effects since they are partly metabolized and degraded through the liver. Hepatic dysfunction is generally not a very serious problem, but caution is required so that adequate monitoring may be done to avoid more severe complications. This paper will summarize the hepatic reactions from the antifungal agents with particular reference to a recently used drug, ketoconazole.
Downloads
Published
1986-07-01
Issue
Section
Case Reports
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
